Alexander Straub

This inventor holds 75 USPTO granted patents and 16 published patent applications, plus 1 CIPO patent and 15 EPO patents, primarily in Pharmaceutical Chemistry (CPC class C07D). Top assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft, Bayer Cropscience Ag. Active years: 1992-2022.

USPTO Granted Patents = 75 (Patent Applications = 16)

% Patents Active = 65.3

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 15 (Patent Applications = 19)

Average Co-Inventor Count = 4.9

ph-index = 16

Forward Citations = 1,045(Granted Patents)

Forward Citations (Not Self Cited) = 932(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Leverkusen, DE (2014)
Wuppertal, DE (1992 - 2022)

Company Filing History:

44 out of 12,266

Bayer Aktiengesellschaft

patents

14 out of 386

Bayer Pharma Aktiengesellschaft

Bayer Schering Pharma Ag

patents

5. 4 out of 77

Bayer Healthcare Aktiengesellschaft

patents

6. 3 out of 721

Bayer Intellectual Property Gmbh

patents

7. 2 out of 39

Makhteshim Chemical Works Ltd.

patents

where one patent can have more than one assignee

Years Active: 1992-2022

Loading Chart...

Areas of Expertise:

Oxazolidinones

Pyrazolopyridines

Muscarinic Receptor

Chymase Inhibitors

Bicyclic Uracils

Anticoagulants

Imidazopyridines

Carbamate Derivatives

Sulfonamide Compounds

2-Oxo-3-Phenyl

Naphthyridine

Thiazoles

75 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11472803 - 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof (2022-10-18),

2. 10927109 - 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof (2021-02-23),

3. 10519154 - 7-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereof (2019-12-31),

4. 10435403 - Positive allosteric modulators of muscarinic M2 receptor (2019-10-08),

5. 10300062 - Bicyclically substituted uracils and the use thereof (2019-05-28),

6. 9949978 - Bicyclically substituted uracils and the use thereof (2018-04-24),

7. 9949977 - Bicyclically substituted uracils and the use thereof (2018-04-24),

8. 9751843 - Substituted uracils and use thereof (2017-09-05),

9. 9695131 - Substituted uracils as chymase inhibitors (2017-07-04),

10. 9481672 - Bicyclically substituted uracils and the use thereof (2016-11-01),

11. 9150580 - Substituted imidazopyridines and the use thereof (2015-10-06),

12. 8946215 - Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use (2015-02-03),

13. 8901311 - Method for producing heterocyclic fluoroalkenyl sulfones (2014-12-02),

14. 8822458 - Substituted oxazolidinones and their use in the field of blood coagulation (2014-09-02),

15. 8778964 - Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use (2014-07-15),

Title: Alexander Straub: Innovator from Wuppertal

Introduction: Alexander Straub is a renowned inventor hailing from Wuppertal, Germany, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Alexander Straub holds several patents in the areas of renewable energy, sustainable transportation, and advanced materials, showcasing his commitment to creating a more sustainable future.

Career Highlights: With over two decades of experience in the industry, Alexander Straub has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized the way we approach environmental challenges.

Collaborations: Throughout his career, Alexander Straub has collaborated with top engineers, scientists, and inventors from around the world, fostering a culture of innovation and knowledge-sharing that has led to numerous successful projects.

Conclusion: Alexander Straub's passion for innovation and his dedication to creating a positive impact on society through his inventions make him a true pioneer in the field of technology.